Nebulized Dosing for an 11 kg Child
For an 11 kg child with acute asthma exacerbation, give salbutamol 0.83 mg (0.075 mg/kg × 11 kg, rounded to minimum 1.25 mg) and ipratropium 0.25 mg every 20 minutes for 3 doses, then as needed. Both medications can be mixed in the same nebulizer 1.
Salbutamol (Albuterol) Dosing
The National Asthma Education and Prevention Program (NAEPP) guidelines provide weight-based dosing for children:
- Initial treatment: 0.075 mg/kg (minimum dose 1.25 mg) every 20 minutes for 3 doses
- Maintenance: 0.075–0.15 mg/kg up to 5 mg every 1–4 hours as needed 1
For your 11 kg patient:
- 0.075 mg/kg × 11 kg = 0.825 mg, but use the minimum 1.25 mg dose
- This ensures adequate bronchodilation while maintaining safety
Ipratropium Bromide Dosing
The guidelines are consistent for pediatric ipratropium dosing:
- 0.25–0.5 mg every 20 minutes for 3 doses, then as needed 1
- Standard pediatric dose is 0.25 mg (250 mcg) per dose 2
- The FDA label confirms 500 mcg as the adult dose, supporting 250 mcg for children 3
Important clinical points:
- Ipratropium should be added to salbutamol for severe exacerbations, not used as monotherapy 1
- The combination is most beneficial in severe asthma, reducing hospital admissions by 27% compared to salbutamol alone 4
- Both drugs can be safely mixed in the same nebulizer if used within 1 hour 1, 3
Practical Administration
- First hour: Give 3 back-to-back treatments (salbutamol 1.25 mg + ipratropium 0.25 mg) at 20-minute intervals
- After initial stabilization: Continue salbutamol 1.25–2.5 mg every 1–4 hours based on response
- Ipratropium benefit diminishes after hospitalization—primarily useful in emergency/acute phase 1
Common Pitfalls to Avoid
- Don't underdose: The minimum 1.25 mg salbutamol dose applies even though weight-based calculation gives 0.83 mg
- Don't use ipratropium as first-line monotherapy—always combine with salbutamol 1
- Don't continue frequent ipratropium beyond the first 3 hours unless severe exacerbation persists 1
- Avoid face masks if possible; use mouthpiece to prevent ocular exposure and risk of angle-closure glaucoma 3
The evidence strongly supports this combination approach in acute severe asthma, with meta-analysis showing particular benefit in severe exacerbations (RR 0.73 for hospital admission) 4, though some individual trials show variable results 5, 6.